INTRODUCTION: Rutin, is a naturally occurring flavonoid found in Ruta graveolens L., and preclinical evidence suggests its potential to regulate oxidative stress, suppress inflammation, and modulate intracellular signaling pathways. This review evaluates the therapeutic potential of rutin, with a particular emphasis on its molecular mechanisms, regulation of gene expression, and potential applications as an adjuvant in gene-targeted therapies.
METHODS: Relevant literature was retrieved from PubMed, Scopus, and Google Scholar using the keywords rutin, preclinical studies, signaling pathways, and gene expression. Peer-reviewed articles published over the last two decades were critically examined for pharmacological, mechanistic, and translational insights.
RESULTS: Rutin has shown strong antioxidant, anti-inflammatory, neuroprotective, cardioprotective, and antidiabetic activities across multiple preclinical models. These effects are mediated by modulation of signaling pathways including PI3K/Akt/mTOR, MAPK, STAT3, β-catenin, and EGFR. Such interactions regulate downstream gene expression and cellular response, highlighting rutin's role as a multi-pathway modulator with a role in future gene-based medicine.
DISCUSSION: Due to a lack of clinical trials, poor solubility, and insufficient bioavailability, rutin exhibits significant preclinical potential but is still understudied. Strong in vivo research and clinical trials are desperately needed, but new multi-omics techniques are enhancing its delivery and mechanistic understanding. To turn rutin into useful treatments, future studies should concentrate on optimal formulations, gene-therapy-related uses, and safety/interaction profiling.
CONCLUSION: Rutin demonstrates significant therapeutic promise by acting as a network modulator that influences multiple interconnected signaling pathways. Future work must prioritize advanced formulations and rigorous clinical studies to validate its potential role as a valuable adjuvant in the fields of precision medicine and gene-based therapies.
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.